Patents by Inventor William J. Kruper

William J. Kruper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020007085
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: December 5, 2000
    Publication date: January 17, 2002
    Applicant: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Patent number: 6312679
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: November 6, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Donald A. Kaplan, William J. Kruper, Jr., Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson
  • Publication number: 20010031895
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: April 4, 2001
    Publication date: October 18, 2001
    Applicant: Merrell Dow Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Patent number: 6291614
    Abstract: A catalyst activator particularly adapted for use in the activation of metal complexes of metals of Group 3-10 for polymerization of ethylenically unsaturated polymerizable monomers, especially olefins, comprising: a compound corresponding to the formula: ArfzAl2Q16-z where; Q1 independently each occurrence is selected from C1-20 alkyl; Arf is a fluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms; z is a number greater than 0 and less than 6, and the moiety: ArfzAl2Q16-z is an adduct of tri(fluoroarylaluminum) with from a sub-stoichiometric to a super-stoichiometric amount of a trialkylaluminum having from 1 to 20 carbons in each alkyl group.
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: September 18, 2001
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, William J. Kruper, Jr.
  • Publication number: 20010021791
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: December 8, 2000
    Publication date: September 13, 2001
    Applicant: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hax, Duane E. Rudisill, Gianbattista Panzone
  • Publication number: 20010020114
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: November 29, 2000
    Publication date: September 6, 2001
    Applicant: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Publication number: 20010018521
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: November 29, 2000
    Publication date: August 30, 2001
    Applicant: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Publication number: 20010018396
    Abstract: Compositions comprising:
    Type: Application
    Filed: January 30, 2001
    Publication date: August 30, 2001
    Inventors: Eugene Y. Chen, Gordon R. Roof, William J. Kruper, David J. Schwarth, Joey W. Storer
  • Patent number: 6268444
    Abstract: This invention relates to heteroatom substituted cyclopentadienyl-containing ligands, metal complexes containing these ligands, catalyst systems prepared from catalyst components comprising these metal complexes. The metal complexes contain a “a” heteroatom-Cp bond or a ring heteroatom-Cp bond in the 3-position of the Cp. In preferred metal complexes the ligand is a 3-heteroatom substituted indenyl group. The catalyst systems for olefin polymerization may be used at high temperatures, are highly active and produce high molecular weight polymer.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: July 31, 2001
    Assignee: Dow Chemical Company
    Inventors: Jerzy Klosin, William J. Kruper, Jr., Peter N. Nickias, Jasson T. Patton, David R. Wilson
  • Patent number: 6242606
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula wherein W represents —C(═O)— or —CH(OH)—; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: June 5, 2001
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Patent number: 6214760
    Abstract: A composition comprising a mixture of aluminum containing Lewis acids said mixture corresponding to the formula: (Arf3Al)(AlQ13)y(—AlQ2—O—)z where; Arf is a fluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms; Q1 is C1-20 alkyl; Q2 is C1-20 hydrocarbyl, optionally substituted with one or more groups which independently each occurrence are hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, di(hydrocarbylsilyl)amino, hydrocarbylamino, di(hydrocarbyl)amino, di(hydrocarbyl)phosphino, or hydrocarbylsulfido groups having from 1 to 20 atoms other than hydrogen, or, optionally, two or more Q2 groups may be covalently linked with each other to form one or more fused rings or ring systems; y is a number from 0 to 1.0; z is a number from 0.1 to 20; and the moieties (Arf3Al)(AlQ13)y may exist as discrete entities or dynamic exchange products.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: April 10, 2001
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, William J. Kruper, Jr., Gordon R. Roof
  • Patent number: 6211111
    Abstract: Compositions comprising: A) an aluminum compound corresponding to the formula AlArf3, where Arf is a fluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms; B) an aluminum compound corresponding to the formula: AlArfQ1Q2, or a dimer, adduct, or mixture thereof; where: Arf is as previously defined; Q1 is Arf or a C1-20 hydrocarbyl group, optionally substituted with one or more cyclohydrocarbyl, hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, hydrocarbylsilyl, silylhydrocarbyl, di(hydrocarbylsilyl)amino, hydrocarbylamino, di(hydrocarbyl)amino, di(hydrocarbyl)phosphino, or hydrocarbylsulfido groups having from 1 to 20 atoms other than hydrogen, or, further optionally, such substituents may be covalently linked with each other to form one or more fused rings or ring systems; and Q2is an aryloxy, arylsulfide or di(hydrocarbyl)amido group, optionally substituted with one or more hydrocarbyl, cyclohydrocarbyl, hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, hydrocarbylsilyl, s
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: April 3, 2001
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, William J. Kruper, Jr., Gordon R. Roof, David J. Schwartz, Joey W. Storer
  • Publication number: 20010000038
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1
    Type: Application
    Filed: December 1, 2000
    Publication date: March 15, 2001
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Patent number: 6187940
    Abstract: Compounds corresponding to the formula: AlArfQ1Q2, or a dimer, adduct, or mixture thereof and further mixtures with aluminum compounds of the formula AlArf3, where: Arf is a fluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms; Q1 is Af or a C1-20 hydrocarbyl group, optionally substituted with one or more cyclohydrocarbyl, hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, hydrocarbylsilyl, silylhydrocarbyl, di(hydrocarbylsilyl)amino, hydrocarbylamino, di(hydrocarbyl)amino, di(hydrocarbyl)phosphino, or hydrocarbylsulfido groups having from 1 to 20 atoms other than hydrogen, or, further optionally, such substituents may be covalently linked with each other to form one or more fused rings or ring systems; and Q2 is an aryloxy, arylsulfide or di(hydrocarbyl)amido group, optionally substituted with one or more hydrocarbyl, cyclohydrocarbyl, hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, hydrocarbylsilyl, silylhydrocarbyl, di(hydrocarbylsilyl)amino, hydrocarbylamino, di(hydroca
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: February 13, 2001
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, William J. Kruper, Jr., Gordon R. Roof, David J. Schwartz, Joey W. Storer
  • Patent number: 6177414
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: January 23, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, William J. Kruper, Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson, Donald A. Kaplan
  • Patent number: 6160146
    Abstract: The monoether adduct of a tri(fluoroaryl)aluminum compound is prepared by an exchange reaction between a trihydrocarbylaluminum compound and a tri(fluororaryl)borane compound in a hydrocarbon solvent in the presence of a C.sub.1-6 aliphatic ether in an amount from 0.9 to 1.0 moles per mole of aluminum.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: December 12, 2000
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, Jerzy Klosin, William J. Kruper, Jr., Robert E. LaPointe
  • Patent number: 6147216
    Abstract: The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula ##STR1## wherein W represents --C(.dbd.O)-- or --CH(OH)--;R.sub.1 represents hydrogen or hydroxy;R.sub.2 represents hydrogen;R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ;n is an integer of from 1 to 5;m is an integer 0 or 1;R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; andpharmaceutically acceptable salts and individual optical isomers thereof,with the proviso that where R.sub.1 and R.sub.2 are ta to form a second bond between the carbon R.sub.1 and R.sub.2 or where R.sub.1 represented hydroxy integer 0.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 14, 2000
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Richard C. Krauss, Robert M. Strom, Carey L. Scortichini, William J. Kruper, Richard A. Wolf, Weishi W. Wu, Albert A. Carr, David A. Hay, Duane E. Rudisill, Gianbattista Panzone
  • Patent number: 6140521
    Abstract: Ansa bis(.mu.-substituted) Group 4 metal and aluminum compounds comprising a single Group 4 metal atom and two aluminum metal atoms corresponding to the formula: ##STR1## wherein: L' is a .pi.-bonded group,M is a Group 4 metal,J is nitrogen or phosphorus;Z is a divalent bridging group causing the complex to have an ansa structure,R' is an inert monovalent ligand;r is one or two;X independently each occurrence is a Lewis basic ligand group able to form a .mu.-bridging ligand group, and optionally the two X groups may be joined together, andA' independently each occurrence is an aluminum containing Lewis acid compound that forms an adduct with the metal complex by means of the .mu.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: October 31, 2000
    Assignee: The Dow Chemical Company
    Inventors: Eugene Y. Chen, William J. Kruper, Jr., Peter N. Nickias, David R. Wilson
  • Patent number: 6086864
    Abstract: The oligomers of the present invention are polythioureas having 3 to 50 recurring units derived from aromatic diamines substituted with anionic groups, and having a number average molecular weight of less than 10,000. These oligomers are water-soluble, preferably have a rigid backbone, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of AIDS.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: July 11, 2000
    Assignees: Merrell Pharmaceuticals Inc., The Dow Chemical Co.
    Inventors: Michael J. Mullins, William A. Fordyce, William J. Kruper, Norton P. Peet, Alan D. Cardin
  • Patent number: 5756065
    Abstract: A group conjugates having a functionalized polyaminocarboxylate chelant that form complexes with rare earth-type metal ions, covalently attached to an antibody or antibody fragment, can be used for therapeutic and/or diagnostic purposes.
    Type: Grant
    Filed: February 15, 1995
    Date of Patent: May 26, 1998
    Assignee: The Dow Chemical Company
    Inventors: David A. Wilson, Joseph R. Garlich, William A. Fordyce, R. Keith Frank, Jaime Simon, William F. Goeckler, Roberta C. Cheng, William J. Kruper, Kenneth McMillan